Research reveals thromboelastography differentiates heparin levels in pediatric cardiac ICU, suggesting it may enhance anticoagulation management.
ΔR showed a moderate correlation with anti-Xa and high discriminative performance in identifying subtherapeutic anticoagulation, thus supporting its use as a surrogate marker for heparin monitoring in PCICUs. However, further external validation and outcome-based studies are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Nishida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: